Phenotypic screens for compounds that target the cellular pathologies underlying Parkinson's disease
Parkinson's disease (PD) is a devastating neurodegenerative disease that affects over one million patients in the US. Yet, no disease modifying drugs exist, only those that temporarily alleviate symptoms. Because of its poorly defined and highly complex disease etiology, it is essential to embr...
Main Authors: | Tardiff, Daniel F., Lindquist, Susan |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | en_US |
Published: |
Elsevier
2016
|
Online Access: | http://hdl.handle.net/1721.1/101272 https://orcid.org/0000-0003-1307-882X |
Similar Items
-
Compounds from an Unbiased Chemical Screen Reverse Both Er-to-Golgi Trafficking Defects and Mitochondrial Dysfunction in Parkinson's Disease Models
by: Su, Linhui Julie, et al.
Published: (2011) -
THE GENERATION OF NEURONAL CELLULAR MODELS FOR THE ANALYSIS OF PARKINSON’S DISEASE RELATED PATHOLOGY
by: Miraj Ud Din Momand, et al.
Published: (2023-10-01) -
Mapping networks of alpha-Synuclein proteostasis in cellular models of Parkinson's disease pathology
by: Lewin, R
Published: (2020) -
Deep Phenotyping of Parkinson’s Disease
by: Dorsey, E. Ray, et al.
Published: (2021) -
High content screening and proteomic analysis identify a kinase inhibitor that rescues pathological phenotypes in a patient-derived model of Parkinson’s disease
by: Nasia Antoniou, et al.
Published: (2022-02-01)